Stay updated with breaking news from Nasdaq oric. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Monaco Asset Management SAM trimmed its holdings in shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) by 31.5% in the second quarter, HoldingsChannel.com reports. The fund owned 378,222 shares of the company’s stock after selling 173,527 shares during the period. ORIC Pharmaceuticals makes up 0.8% of Monaco Asset Management SAM’s investment portfolio, making the […] ....
Wedbush reissued their outperform rating on shares of ORIC Pharmaceuticals (NASDAQ:ORIC – Free Report) in a research report released on Monday, Benzinga reports. The firm currently has a $14.00 price target on the stock. ORIC has been the topic of a number of other research reports. Robert W. Baird raised their price objective on shares […] ....
Wedbush restated their outperform rating on shares of ORIC Pharmaceuticals (NASDAQ:ORIC – Free Report) in a research report sent to investors on Monday, Benzinga reports. They currently have a $14.00 price objective on the stock. Several other brokerages have also issued reports on ORIC. Citigroup lifted their price target on ORIC Pharmaceuticals from $8.00 to […] ....
CNS activity observed at multiple dose levels, including the first reported confirmed CNS complete response by an EGFR exon 20 inhibitor in a patient with. ....
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) has earned an average rating of “Buy” from the seven research firms that are currently covering the stock, MarketBeat.com reports. Seven equities research analysts have rated the stock with a buy rating. The average twelve-month target price among analysts that have issued ratings on the stock in […] ....